Annual EBIT
-$123.99 M
+$33.14 M+21.09%
31 December 2023
Summary:
Adverum Biotechnologies annual earnings before interest & taxes is currently -$123.99 million, with the most recent change of +$33.14 million (+21.09%) on 31 December 2023. During the last 3 years, it has fallen by -$6.04 million (-5.12%). ADVM annual EBIT is now -6776.93% below its all-time high of -$1.80 million.ADVM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$29.22 M
-$8.34 M-39.93%
30 September 2024
Summary:
Adverum Biotechnologies quarterly earnings before interest & taxes is currently -$29.22 million, with the most recent change of -$8.34 million (-39.93%) on 30 September 2024. Over the past year, it has increased by +$5.31 million (+15.37%). ADVM quarterly EBIT is now -81069.44% below its all-time high of -$36.00 thousand, reached on 31 March 2013.ADVM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$103.10 M
+$5.31 M+4.90%
30 September 2024
Summary:
Adverum Biotechnologies TTM earnings before interest & taxes is currently -$103.10 million, with the most recent change of +$5.31 million (+4.90%) on 30 September 2024. Over the past year, it has increased by +$28.67 million (+21.76%). ADVM TTM EBIT is now -286288.89% below its all-time high of -$36.00 thousand, reached on 31 March 2013.ADVM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.1% | +15.4% | +21.8% |
| 3 y3 years | -5.1% | +24.1% | +30.4% |
| 5 y5 years | -69.7% | -71.0% | -57.0% |
ADVM EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.1% | +21.1% | -39.9% | +33.6% | at high | +34.6% |
| 5 y | 5 years | -80.9% | +21.1% | -71.0% | +34.4% | -57.0% | +34.6% |
| alltime | all time | -6776.9% | +21.1% | <-9999.0% | +34.4% | <-9999.0% | +34.6% |
Adverum Biotechnologies EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$29.22 M(+39.9%) | -$103.10 M(-4.9%) |
| June 2024 | - | -$20.88 M(-22.2%) | -$108.41 M(-10.1%) |
| Mar 2024 | - | -$26.84 M(+2.6%) | -$120.59 M(-2.7%) |
| Dec 2023 | -$123.99 M(-21.1%) | -$26.16 M(-24.2%) | -$123.99 M(-5.9%) |
| Sept 2023 | - | -$34.53 M(+4.4%) | -$131.77 M(-4.7%) |
| June 2023 | - | -$33.06 M(+9.3%) | -$138.28 M(-7.3%) |
| Mar 2023 | - | -$30.24 M(-10.9%) | -$149.24 M(-5.0%) |
| Dec 2022 | -$157.13 M(+7.5%) | -$33.94 M(-17.3%) | -$157.13 M(-0.3%) |
| Sept 2022 | - | -$41.04 M(-6.8%) | -$157.61 M(+1.6%) |
| June 2022 | - | -$44.02 M(+15.5%) | -$155.10 M(-0.3%) |
| Mar 2022 | - | -$38.13 M(+10.8%) | -$155.61 M(+6.5%) |
| Dec 2021 | -$146.12 M(+23.9%) | -$34.42 M(-10.7%) | -$146.12 M(-1.3%) |
| Sept 2021 | - | -$38.52 M(-13.5%) | -$148.08 M(+7.6%) |
| June 2021 | - | -$44.54 M(+55.5%) | -$137.56 M(+12.0%) |
| Mar 2021 | - | -$28.64 M(-21.3%) | -$122.80 M(+4.1%) |
| Dec 2020 | -$117.95 M(+72.1%) | -$36.38 M(+29.9%) | -$117.95 M(+16.5%) |
| Sept 2020 | - | -$28.00 M(-5.9%) | -$101.22 M(+12.1%) |
| June 2020 | - | -$29.77 M(+25.2%) | -$90.30 M(+17.8%) |
| Mar 2020 | - | -$23.79 M(+21.1%) | -$76.63 M(+11.8%) |
| Dec 2019 | -$68.55 M(-6.2%) | -$19.65 M(+15.0%) | -$68.55 M(+4.4%) |
| Sept 2019 | - | -$17.08 M(+6.1%) | -$65.65 M(-2.1%) |
| June 2019 | - | -$16.10 M(+2.5%) | -$67.04 M(-5.4%) |
| Mar 2019 | - | -$15.71 M(-6.3%) | -$70.84 M(-3.1%) |
| Dec 2018 | -$73.08 M | -$16.76 M(-9.3%) | -$73.08 M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$18.47 M(-7.2%) | -$71.92 M(+5.7%) |
| June 2018 | - | -$19.90 M(+10.9%) | -$68.02 M(+13.0%) |
| Mar 2018 | - | -$17.95 M(+15.1%) | -$60.20 M(+2.3%) |
| Dec 2017 | -$58.85 M(+7.8%) | -$15.60 M(+7.0%) | -$58.85 M(+6.1%) |
| Sept 2017 | - | -$14.57 M(+20.5%) | -$55.44 M(+0.8%) |
| June 2017 | - | -$12.09 M(-27.1%) | -$54.98 M(-1.2%) |
| Mar 2017 | - | -$16.59 M(+36.1%) | -$55.65 M(+2.0%) |
| Dec 2016 | -$54.57 M(+20.6%) | -$12.19 M(-13.6%) | -$54.57 M(+1.1%) |
| Sept 2016 | - | -$14.11 M(+10.6%) | -$53.99 M(-0.2%) |
| June 2016 | - | -$12.76 M(-17.7%) | -$54.08 M(+5.6%) |
| Mar 2016 | - | -$15.51 M(+33.6%) | -$51.20 M(+13.1%) |
| Dec 2015 | -$45.25 M(+78.2%) | -$11.61 M(-18.3%) | -$45.25 M(+2.8%) |
| Sept 2015 | - | -$14.20 M(+43.7%) | -$44.03 M(+15.6%) |
| June 2015 | - | -$9.88 M(+3.4%) | -$38.09 M(+14.4%) |
| Mar 2015 | - | -$9.56 M(-8.0%) | -$33.30 M(+31.2%) |
| Dec 2014 | -$25.39 M(+387.9%) | -$10.39 M(+25.9%) | -$25.39 M(+35.9%) |
| Sept 2014 | - | -$8.26 M(+62.2%) | -$18.68 M(+66.7%) |
| June 2014 | - | -$5.09 M(+208.7%) | -$11.21 M(+64.4%) |
| Mar 2014 | - | -$1.65 M(-55.2%) | -$6.82 M(+31.0%) |
| Dec 2013 | -$5.20 M(+188.6%) | -$3.68 M(+368.9%) | -$5.20 M(+241.9%) |
| Sept 2013 | - | -$785.00 K(+12.0%) | -$1.52 M(+106.5%) |
| June 2013 | - | -$701.00 K(+1847.2%) | -$737.00 K(+1947.2%) |
| Mar 2013 | - | -$36.00 K | -$36.00 K |
| Dec 2012 | -$1.80 M | - | - |
FAQ
- What is Adverum Biotechnologies annual earnings before interest & taxes?
- What is the all time high annual EBIT for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual EBIT year-on-year change?
- What is Adverum Biotechnologies quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly EBIT year-on-year change?
- What is Adverum Biotechnologies TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Adverum Biotechnologies?
- What is Adverum Biotechnologies TTM EBIT year-on-year change?
What is Adverum Biotechnologies annual earnings before interest & taxes?
The current annual EBIT of ADVM is -$123.99 M
What is the all time high annual EBIT for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual earnings before interest & taxes is -$1.80 M
What is Adverum Biotechnologies annual EBIT year-on-year change?
Over the past year, ADVM annual earnings before interest & taxes has changed by +$33.14 M (+21.09%)
What is Adverum Biotechnologies quarterly earnings before interest & taxes?
The current quarterly EBIT of ADVM is -$29.22 M
What is the all time high quarterly EBIT for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly earnings before interest & taxes is -$36.00 K
What is Adverum Biotechnologies quarterly EBIT year-on-year change?
Over the past year, ADVM quarterly earnings before interest & taxes has changed by +$5.31 M (+15.37%)
What is Adverum Biotechnologies TTM earnings before interest & taxes?
The current TTM EBIT of ADVM is -$103.10 M
What is the all time high TTM EBIT for Adverum Biotechnologies?
Adverum Biotechnologies all-time high TTM earnings before interest & taxes is -$36.00 K
What is Adverum Biotechnologies TTM EBIT year-on-year change?
Over the past year, ADVM TTM earnings before interest & taxes has changed by +$28.67 M (+21.76%)